Prestige Biopharma | A Frontier in Biopharmaceuticals
  • Company
    • About Us
    • History
    • Our Purpose
    • Our Responsibilty
  • Global R&D
    • Global Campus
    • Research, Singapore
    • IDC R&D
  • Pipeline
    • Biosimilar
      • Overview
      • Tuznue™
      • HD204
      • PBP1502
    • Innovative Drug
      • Overview
      • PBP1510
      • PBP1710
      • IDC001
      • mAbs
      • bs-Abs
      • Fusion-Abs
    • Vaccines
    • Diagnostics
    • PAUF
  • Investors
    • Financial Information
    • Stock Information
    • Disclosure
  • Newsroom
    • News
    • Media
    • PR Materials
  • Careers
  • Contact
  • 한국어
Select Page

News

NEWS | Innovation for Life

Prestige Biopharma Group Participates in BIO USA 2024 Exhibition

Date
2024-06-04 14:01
Views
1880
Vote
0






BIO USA 2024 has opened today in the United States.

Prestige Biopharma Group is continuing with over 30 meetings on the first day.

All employees are committed to doing their best to achieve successful outcomes.

« Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
CPHI Milan 2024 »
List

Contact

Biosimilars
Overview
HD201
HD204
PBP1502
First-in-Class Antibody
Overview
PBP1510
PBP1710
IDC001
mAbs
bs-Abs
Fusion-Abs

Vaccines

Diagnosics

PAUF

Global R&D
Global Campus
Research Center, Singapore
IDC R&D

Investors

Careers

Company
About us
History
Our Purpose
Our Responsibility
Newsroon
News
Media
PR Materials

Contact

Pipeline

Biosimilars

Overview

HD201

HD204

PBP1502

First-in-Class Antibody

Overview

PBP1510

PBP1710

IDC001

mAbs

bs-Abs

fusion-Abs

Vaccines

Diagnostics

PAUF

Global R&D

Global Campus

Research Center, Singapore

IDC R&D

Investors

Careers

Company

About Us

History

Our Purpose

Our Responsibiltiy

Newsroom

News

Media

PR Materials

Copyright © 2023 Prestige Biopharma Ltd. All Rights Reserved. 

Connect with us on LinkedIn | Data Policy

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Prestige Biopharma Group Sites


  • o
  • o
  • 한국어 (Korean)